J Thorac Oncol 2021 Aug 26
Brain Metastases in EGFR- and ALK-Positive NSCLC: Outcomes of Central Nervous System-Penetrant Tyrosine Kinase Inhibitors Alone Versus in Combination With Radiation.
Related Questions
Can SRS or whole brain radiotherapy be reserved for progression in these young, healthy patients?
New comment by Medical Oncologist at NYU Winthrop Hospital ( June 9, 2025)
Avoid radiation in small asymptomatic brain metastases.
Use TKI: Osimertinib.
Follow up with brain MRI frequently.